Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$4.19 USD
+0.08 (1.95%)
Updated May 3, 2024 04:00 PM ET
After-Market: $4.18 -0.01 (-0.24%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: BMO |
3/2024 | $-0.10 | -53.92% |
Earnings Summary
For their last quarter, Autolus Therapeutics (AUTL) reported earnings of -$0.44 per share, missing the Zacks Consensus Estimate of -$0.26 per share. This reflects a negative earnings surprise of 69.23%. Look out for AUTL's next earnings release on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.10 per share, reflecting a year-over-year increase of 56.52%.
Earnings History
Price & Consensus
Zacks News for AUTL
Strength Seen in Autolus Therapeutics PLC Sponsored ADR (AUTL): Can Its 6.3% Jump Turn into More Strength?
AUTL: What are Zacks experts saying now?
Zacks Private Portfolio Services